Egypt vs Qatar: Access to anti-retroviral drugs, female
Egypt
46.0%
in 2024
Qatar
43.0%
in 2024
Egypt rank
125th
Qatar rank
126th
Access to anti-retroviral drugs, female over time
- Egypt
- Qatar
How they compare
Egypt currently reports 46.0% against 43.0% in Qatar, a difference of 3.0%.
That makes Egypt's figure about 1.1 times Qatar's.
The two have swapped places 1 time across 17 shared years of data; in 2000 it was Qatar ahead.
Egypt ranks 125th and Qatar ranks 126th of 141 countries.
Qatar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Egypt | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 22.2% | 85.2% | 63.0% | Qatar |
| 2020s | 36.8% | 53.0% | 16.2% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Egypt or Qatar?
- Egypt, at 46.0% against 43.0% in Qatar as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Egypt and Qatar?
- 3.0%, with Egypt ahead.
- How many years of comparable data are there for Egypt and Qatar?
- 17 years are reported by both, from 2000 to 2024.
- How do Egypt and Qatar rank globally for access to anti-retroviral drugs, female?
- Egypt ranks 125th and Qatar ranks 126th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.